A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Key facts

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Intervention

Nebulized Ensifentrine Suspension; 3 mg(drug)

Enrollment

284 target

Eligibility

18-80 years · All sexes

Timeline

2024 – 2027

Study locations (30)

• Kirklin Clinic of UAB Hospital, Birmingham, Alabama, United States
• So Cal Institute for Respiratory Diseases, Inc., Los Angeles, California, United States
• University of California Davis Medical Center, Sacramento, California, United States
• National Jewish Health Main Campus, Denver, Colorado, United States
• MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
• University of Miami, Miami, Florida, United States
• Emory University at Saint Joseph Pulmonary Clinic, Atlanta, Georgia, United States
• Augusta University, Augusta, Georgia, United States
• ASHA Clinical Research, Hammond, Indiana, United States
• University of Iowa, Iowa City, Iowa, United States
• University of Kansas Medical Center-Kansas City, Kansas City, Kansas, United States
• Massachusetts General Hospital- 55 Fruit St, Boston, Massachusetts, United States
• University of Michigan Hospital, Ann Arbor, Michigan, United States
• Mayo Clinic, Rochester, Minnesota, United States
• Washington University School of Medicine, St Louis, Missouri, United States
• +15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07071324
  CF Wellness Program
  Johns Hopkins University
• RECRUITINGNANCT07223255
  Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
  Dartmouth-Hitchcock Medical Center
• RECRUITINGNANCT07031323
  OnTrackCF: Engagement, Feasibility, and Acceptability Study
  Boston Children's Hospital
• ACTIVE NOT RECRUITINGNCT07147803
  Sleep Quality in Patients With Non-cystic Fibrosis Bronchiectasis
  Assiut University
• RECRUITINGPHASE2NCT06998043
  Study With Phage for CF Subjects With Pseudomonas Lung Infection
  BiomX Ltd
• RECRUITINGNCT06683092
  Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
  Boston Children's Hospital
• RECRUITINGPHASE4NCT05704036
  Estrogen Supplementation and Bone Health in Women With CF
  Johns Hopkins University
• RECRUITINGNCT06274840
  COVID-19 Antibody Responses In Cystic Fibrosis
  Pilar Azevedo

See all trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome →